- Sections
- A - Nécessités courantes de la vie
- A61P - Activité thérapeutique spécifique de composés chimiques ou de préparations médicinales
- A61P 33/04 - Amoebicides
Détention brevets de la classe A61P 33/04
Brevets de cette classe: 73
Historique des publications depuis 10 ans
|
8
|
1
|
4
|
4
|
1
|
10
|
6
|
5
|
8
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| CJ Cheiljedang Corporation | 3686 |
5 |
| Nihon Nohyaku Co., Ltd. | 327 |
4 |
| The University of Tokyo | 4390 |
4 |
| Nutreco IP Assets B.V. | 191 |
3 |
| Access to Advanced Health Institute | 75 |
3 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 173 |
2 |
| Santen Pharmaceutical Co., Ltd. | 593 |
2 |
| Universidad de La Laguna | 47 |
2 |
| University of The West of Scotland | 17 |
2 |
| Profounda Health and Beauty Inc. | 17 |
2 |
| Massachusetts Institute of Technology | 10305 |
1 |
| Wisconsin Alumni Research Foundation | 3903 |
1 |
| Purdue Research Foundation | 3962 |
1 |
| The Australian National University | 198 |
1 |
| Clemson University | 192 |
1 |
| Commonwealth Scientific and Industrial Research Organisation | 1649 |
1 |
| Evofem Biosciences, Inc. | 50 |
1 |
| Georgia State University Research Foundation, Inc. | 361 |
1 |
| H Sulphur Corp. | 8 |
1 |
| Industry-Academic Cooperation Foundation Gyeongsang National University | 635 |
1 |
| Autres propriétaires | 34 |